← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Betastem Therapuetics, Inc.
San Francisco, CA
$2,268,039
Total funding
5
Grants
Funding over time
peak $1.1M · FY2007–17$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,268,039 · 5
By mechanism
RC1$996,184 · 1
R43$611,686 · 2
R44$461,417 · 1
R41$198,752 · 1
Investigators at Betastem Therapuetics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
A Cellular Approach to the Treatment of Diabetic Maculopathy$499,259
RC1 · FY2010 · EY
A Cellular Approach to the Treatment of Diabetic Maculopathy$496,925
RC1 · FY2009 · EY
Autologous TGFB1 Modified CD34+ Stem Cells for Repair of Diabetic Macular Edema and Macular Ischemia$461,417
R44 · FY2017 · EY
Autologous TGF-B-Modified HSC for Repair of Vasodegenerative Diabetic Retinopathy$326,697
R43 · FY2009 · EY
Accelerated Repair of Vascular Injury in Diabetes by TGF-beta Modified Stem Cells$284,989
R43 · FY2009 · HL
Progenitor assay to screen proteins/molecules for treatment of type1 diabetes$198,752
R41 · FY2007 · DK